GILDER GAGNON HOWE & CO LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$473,000
+19.4%
27,8820.0%0.01%
+25.0%
Q2 2018$396,000
-25.3%
27,882
-0.1%
0.00%
-42.9%
Q1 2018$530,000
+15.5%
27,916
-0.3%
0.01%
+16.7%
Q4 2017$459,000
-1.1%
27,992
-9.5%
0.01%
-14.3%
Q3 2017$464,000
-9.7%
30,923
-47.0%
0.01%
-12.5%
Q2 2017$514,000
+233.8%
58,378
+97.4%
0.01%
+166.7%
Q1 2017$154,00029,5760.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders